In this systematic review, we aimed to examine current evidence regarding the relationship between pregestational maternal insulin-related metabolic conditions (T1DM, T2DM, and PCOS) and maternal PRL levels in pregnancy and postpartum, as well as the association between PRL and key fetal outcomes in these conditions. This evidence concerns the gene INS and type 1 diabetes mellitus.